XGenomes Patents

Patent portfolio assigned to XGenomes (verified via public assignee records). Single-molecule DNA-sequencing startup (XGenomes Corp., Boston). Patents confirmed under assignee XGenomes Corp. (e.g. US10982260B2 'Sequencing by emergence'; US20200082913A1; EP3887545A1). Early-stage / access-as-a-service model: no named customers disclosed; direct competitors not sourced from a fetched neutral page this task.